Bure Equity AB (BURE) AI Stock Analysis

• Market Cap: €20.38B
• Dividend Yield: 0.97%
• Average Volume (3M): 61.91K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.16
• Revenue Growth: 22.27%
• EPS Growth: -145.59%
• Country: SE
• Employees: 10
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): -16.84
• Shares Outstanding: 74,146,920
• 10 Day Avg. Volume: 69,881
• 30 Day Avg. Volume: 61,907
• PEG Ratio: 0.23
• Price to Book (P/B): 1.15
• Price to Sales (P/S): 117.47
• P/FCF Ratio: 164.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 60 Neutral
• Price Target: kr294.00 ▲(3.30% Upside)

Bure Equity AB's overall stock score is driven by its strong financial performance, particularly its robust balance sheet and profitability metrics. However, the technical analysis indicates bearish trends, and the valuation is concerning due to a negative P/E ratio. The absence of significant earnings call insights or corporate events leaves the financial performance as the primary factor in the score.

Bure Equity AB Business Overview & Revenue Model

Company Description

Bure Equity AB (BURE) is a Swedish investment company that specializes in acquiring and managing a diverse portfolio of companies across various sectors, including technology, healthcare, and finance. The company focuses on identifying growth opportunities in both established and emerging businesses, leveraging its expertise to drive value creation. BURE's core services include active management and strategic support for its portfolio companies, which aims to enhance operational efficiency and market positioning.

How the Company Makes Money

Bure Equity AB generates revenue primarily through its investments in portfolio companies, which yield returns in the form of dividends, interest income, and capital gains upon exit. The company employs a strategy of long-term investments, enabling it to benefit from the appreciation of its holdings over time. Additionally, BURE may engage in management fees and performance-based compensation from its subsidiaries, contributing to its overall earnings. Strategic partnerships with other investment firms and industry players further bolster its financial performance, allowing for co-investing opportunities and sharing of resources to maximize returns.

Bure Equity AB Financial Statement Overview

Summary

Bure Equity AB demonstrates strong financial performance with high profitability and a solid balance sheet. The company benefits from a high net profit margin and low debt levels, indicating financial stability. However, the reliance on non-operational income and declining cash flows are areas of concern.

Income Statement

Bure Equity AB has shown strong revenue growth from 2023 to 2024 with a notable increase in total revenue by 9.05%. The company maintains an impressive net profit margin of 2381.74% for 2024, highlighting exceptional profitability, although this is largely due to significant other income or one-time gains. Gross profit margins are robust at 70.54%. EBIT and EBITDA margins are extremely high, which can be indicative of non-operational income inflating these figures. Despite these strengths, the revenue for 2024 remains modest compared to earlier years, possibly reflecting market conditions or strategic shifts.

Balance Sheet

Bure Equity AB exhibits a very strong balance sheet with a minimal debt-to-equity ratio of 0.0001, indicating low financial leverage. This is complemented by a very high equity ratio of 99.77% for 2024, showcasing financial stability and low debt reliance. The company's return on equity is remarkably high at 23.26%, driven by substantial net income. The high equity ratio and low debt levels suggest a conservative financial strategy, which enhances financial robustness and mitigates risk.

Cash Flow

The cash flow statement reveals mixed performance with a significant decline in operating cash flow from 2023 to 2024. Free cash flow also decreased substantially during this period. The free cash flow to net income ratio is relatively low, indicating that net income is not fully translating to cash flow. However, the company maintains positive free cash flow, supporting its operations without external funding. The operating cash flow to net income ratio suggests that operational activities contribute less to cash generation than net income, possibly due to non-operational income influencing net results.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	279.00M	241.00M	221.00M	217.00M	197.00M	77.00M
Gross Profit	210.00M	170.00M	4.81B	-9.17B	146.00M	3.35B
EBITDA	-2.90B	5.74B	4.75B	-9.24B	6.36B	3.29B
Net Income	-2.90B	5.74B	4.75B	-9.24B	6.35B	3.29B
Balance Sheet
Total Assets	20.63B	24.74B	19.19B	14.64B	24.00B	17.93B
Cash, Cash Equivalents and Short-Term Investments	675.00M	782.00M	1.58B	532.00M	459.00M	1.46B
Total Debt	2.00M	3.00M	3.00M	3.00M	4.00M	3.00M
Total Liabilities	23.00M	52.00M	57.00M	95.00M	48.00M	232.30M
Stockholders Equity	20.60B	24.68B	19.12B	14.54B	23.94B	17.68B
Cash Flow
Free Cash Flow	182.00M	172.00M	1.37B	160.00M	958.00M	37.00M
Operating Cash Flow	182.00M	172.00M	1.37B	176.00M	980.00M	59.30M
Investing Cash Flow	-335.00M	-778.00M	-124.00M	39.00M	-1.67B	-432.60M
Financing Cash Flow	-204.00M	-201.00M	-206.00M	-125.00M	-151.00M	916.00M

Bure Equity AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 284.60
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:BURE, the sentiment is Positive. The current price of 284.6 is above the 20-day moving average (MA) of 277.97, above the 50-day MA of 278.89, and below the 200-day MA of 311.00, indicating a neutral trend. The MACD of 0.28 indicates Negative momentum. The RSI at 56.51 is Neutral, neither overbought nor oversold. The STOCH value of 85.36 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:BURE.

Bure Equity AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRED.A	―	kr10.56B	8.05	12.47%	2.03%	4.72%	-38.28%
MCAP	―	€8.35B	41.68	15.16%	―	11.30%	-14.49%
Sector *	―	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
RATO.B	―	kr12.79B	15.36	6.59%	3.48%	-22.65%	-14.05%
BURE	―	€20.38B	―	-13.33%	0.97%	22.27%	-145.59%
KINV.B	―	kr24.46B	198.30	0.33%	―	-97.64%	―
KINV.A	―	€24.46B	201.25	―	―	-97.64%	―

Bure Equity AB Corporate Events

Bure Equity AB Announces Share Structure Adjustment

Bure Equity AB has announced a change in its share structure due to the conversion of class C shares into ordinary shares. This adjustment, aimed at fulfilling the company’s long-term incentive program, slightly alters the distribution of shares and votes, reflecting Bure’s ongoing commitment to its strategic initiatives.

The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK288.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.

Bure Equity AB Forms Nominating Committee for 2026 AGM

Bure Equity AB has announced the formation of its Nominating Committee for the 2026 annual general meeting, comprising representatives from its largest shareholders and the Chairman of the Board. This committee, representing 36.4% of voting shares, will play a crucial role in shaping the company’s governance and strategic direction ahead of the meeting scheduled for May 2026.

The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK308.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.

Bure Equity AB Reports Decline in Net Asset Value Amid Strategic Investments

Bure Equity AB reported a decrease in net asset value by 16.5% in the first half of 2025, with significant investment activities including acquiring a 17% stake in Silex Microsystems, a leader in MEMS foundry services. The company faced mixed performance from its portfolio companies, with notable growth in Mycronic and a significant order for Ovzon, while others like Vitrolife and Xvivo experienced challenges. The acquisition of Silex is seen as a strategic move to enhance growth opportunities amid geopolitical complexities.

Bure Equity AB Finalizes Acquisition of Silex Microsystems

Bure Equity AB has completed the acquisition of a 17% stake in Silex Microsystems, a leading Swedish semiconductor company, as part of a consortium of Swedish investors. This acquisition, which results in the consortium and Silex’s management holding a majority stake, is expected to strengthen Silex’s market position and support its growth in the global technology sector.